NCT04180826

Brief Summary

Ischemic strokes account for more than 80% of strokes. Ischemic strokes are caused by the occlusion of an intracranial artery by a thrombus, responsible for tissue ischemia related to a decrease in local cerebral blood flow (CBS). Thus, the management of patients with Ischemic strokes is based on the preservation of an area that maintains sufficient intracranial hemodynamics (IH) and achieves the fastest possible recanalization. The impact of the patient's position (supine or seated position) on the IH in the event of narrowing or occlusion of an artery is poorly assessed but may be of particular importance. In practice, variations in blood flow according to the positioning of the patient's body can be measured using a transcranial Doppler. It is a simple, non-invasive and painless examination that provides the patient's bed with data on the intracerebral hemodynamic profile of patients. This study was implemented because there are no studies known to us that evaluate the effect of verticalization on intracerebral hemodynamics based on the presence of upstream arterial stenosis or occlusion and other multimodal evaluation data in transcranial Doppler.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 29, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2021

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

November 26, 2019

Last Update Submit

March 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the monitoring of patient care

    drop of more than 10% of the mean velocity between the supine and seated position

    2 minutes after verticalization

Study Arms (2)

Stenosis

Patients with stenosis

Other: Observational

No stenosis

Patients without stenosis

Other: Observational

Interventions

Initially, the patient will be placed in a strict supine position (at 0°) in his hospital bed, according to the usual care. In a second step, the patient will be verticalized (from 0° to 90°). Intracranial hemodynamics parameters in supine position and during verticalization will be continuously recorded by attaching the ATYS TCD-X® transcranial Doppler helmet attached with glasses. After 15 minutes of recording, the patient will be placed back in supine position. The end of the patient's participation in the study will correspond to the removal of the ATYS TCD-X® helmet.

No stenosisStenosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with ischemic stroke or transient ischemic attack of less than 48 hours with or without carotid stenosis greater than 50% NASCET or occlusion

You may qualify if:

  • Patient over 18 years of age
  • acute ischemic stroke or transient ischemic attack
  • symptoms onset \< 48 hours
  • Absence of homolateral or downstream intracranial stenosis or M1 occlusion
  • Verticalization authorized by the referent clinician.
  • Rankin's score before AIC/AIT ≤ 2
  • Non-opposition to participation in the study
  • \- Carotid stenosis of more than 50% NASCET or an occlusion
  • Criteria for including witnesses - Absence of carotid stenosis greater than 50% NASCET or occlusion
  • \- Disrupted vigilance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mikaël Mazighi

Paris, France

Location

MeSH Terms

Conditions

Ischemic StrokeCarotid Stenosis

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCarotid Artery DiseasesArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2019

First Posted

November 29, 2019

Study Start

January 15, 2019

Primary Completion

January 15, 2021

Study Completion

March 3, 2021

Last Updated

March 4, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations